Bezos’s Prometheus Raises $12 Billion at $41 Billion Valuation
Jeff Bezos’s industrial AI startup Prometheus raised $12 billion at a $41 billion valuation, emerging from stealth to build AI for engineering and manufacturing.
Research & Innovation
Comprehensive coverage of academic breakthroughs, patents, labs and experimental models pushing the frontiers of technology. Discover how cutting-edge research turns into practical innovation across industries and influences the next generation of products. This category captures the pipeline from idea to market.
Anthropic Launches Claude Fable 5 for General Use and Mythos 5 for Vetted Partners
Anthropic has released Claude Fable 5, its most capable model available to the general public, alongside Claude Mythos 5 – an identical underlying model with key safety restrictions removed, available only to approved cybersecurity and research partners.
OpenAI Launches Rosalind Biodefense Program for Public Health Research
OpenAI has launched the Rosalind Biodefense program and expanded access to its GPT-Rosalind model for trusted developers and government partners. The initiative aims to accelerate biodefense, pandemic preparedness, and public health research using advanced AI tools.
Nvidia Invests $6.5 Billion in Technology That Could Reshape AI Infrastructure
By
Laura Bennett
• 3 mins read
Nvidia has committed at least $6.5 billion to photonics companies in recent months as it seeks to overcome AI infrastructure bottlenecks. The investments target optical technologies that could reduce energy consumption and improve data transfer across future AI systems.
Google DeepMind Says AlphaProof Nexus Solved Nine Open Erdős Problems
By
Laura Bennett
• 3 mins read
Google DeepMind says its new AlphaProof Nexus framework solved nine open Erdős problems using AI-guided formal verification, though CEO Demis Hassabis cautioned the system is still far from AGI.
Unreleased OpenAI Model Solves Longstanding Erdős Geometry Problem
By
Laura Bennett
• 3 mins read
OpenAI says one of its unreleased reasoning models solved a major combinatorial geometry problem first posed by Paul Erdős in 1946. The result challenges a decades-old mathematical conjecture and marks a new milestone for AI-assisted research.
Andrej Karpathy Joins Anthropic as AI Race Intensifies
By
Samantha Reed
• 2 mins read
Anthropic has hired prominent AI researcher Andrej Karpathy as the company accelerates efforts to compete with OpenAI and Google.
Nvidia Teams Up with DeepMind Veteran for AI Superintelligence Research
By
Laura Bennett
• 3 mins read
Nvidia has partnered with AI startup Ineffable Intelligence to develop large-scale reinforcement learning systems aimed at superintelligence research. The company was founded in late 2025 by former Google DeepMind researcher David Silver.
Recursive Superintelligence Raises $500M to Build Self-Improving AI
By
Laura Bennett
• 3 mins read
AI startup Recursive Superintelligence has raised $500 million from Nvidia and GV to pursue self-improving AI systems, despite having no public product.
OpenAI Launches GPT-Rosalind for Biology and Drug Discovery
By
Laura Bennett
• 3 mins read
OpenAI has introduced GPT-Rosalind, a specialized AI model for life sciences research. The system aims to accelerate drug discovery and biological analysis workflows.
NTU Singapore Develops AI-Powered Biochip for Rapid Disease Detection
By
Laura Bennett
• 3 mins read
Researchers at NTU Singapore have developed an AI-powered biochip that detects disease-linked microRNAs in minutes. The system could enable faster, more precise diagnostics.
AWS Launches Amazon Bio Discovery to Accelerate Drug Design
By
Laura Bennett
• 3 mins read
AWS has launched Amazon Bio Discovery, an AI-powered platform that helps scientists design, test, and refine drugs faster using integrated models and lab workflows.
Novo Nordisk Partners With OpenAI to Accelerate Drug Discovery
By
Laura Bennett
• 3 mins read
Novo Nordisk is teaming up with OpenAI to use AI in drug discovery and development, aiming to speed up treatments for obesity and diabetes.
Mantis Biotech Builds AI ‘Digital Twins’ to Transform Healthcare Research
By
Laura Bennett
• 2 mins read
Mantis Biotech is developing AI-powered digital twins to generate synthetic biomedical data and improve research across healthcare and life sciences.
Eli Lilly Signs $2.75B Deal to Bring AI-Developed Drugs to the Global Market
By
Laura Bennett
• 2 mins read
Eli Lilly has signed a $2.75 billion deal with Insilico Medicine to commercialize AI-developed therapies globally.